Categories
Connect with us on LinkedIn
Accelerating Enrollment for Direct-to-Patient Observational Studies: A Case Study in Traveler’s Diarrhea
Discover how TrialScreen and Castor closed enrollment three months early on a fully virtual, direct-to-patient study (Travelers Diarrhea),...
Inside the Curavit and Lindus CRO deal
The decentralized trial hype has faded, but the direct-to-patient model has matured, and the teams running it now...
Castor Catalyst is the first to market to show industry-leading data extraction accuracy in a sponsor-audit-friendly technical approach
Castor Catalyst, Castor's AI-driven clinical data platform, reads data directly from source records and proposes each value for...
When patients enroll themselves, studies fill about six times faster
Self-selected and self-served: does patient-led digital enrollment predict downstream data completeness in real-world evidence studies?
Inside the Curavit and Lindus deal: what unified US and European trial delivery really takes
Curavit has acquired Lindus Health's CRO assets, bringing US and European trial delivery under one roof while Lindus...
Next-Generation Digital Study Infrastructure LinkedIn Live
The decentralized trial hype has faded, but the direct-to-patient model has matured, and the teams running it now...
Survey Compliance Dashboard
ePRO compliance usually lives in a spreadsheet, so a study team learns weeks late. Filter to participants below...
Targeted Source Data Verification
Verifying every field burns monitoring hours. Set a global or site-specific SDV plan in one click, and get...
Query Management
System-generated and manual queries side by side, each opening onto its audit trail, comments and field history. Answer...
FormSync Mid-Study Changes
Watch the FormSync demo: build and test a mid-study protocol amendment in a linked study, then merge it...
Monitoring: Queries and SDV
Queries and source data verification in one monitoring tab, each query with its audit trail, plus targeted SDV...
End-to-End ePRO Process
A separate ePRO vendor means a second build and a reconciliation step. Build surveys in the same study...
Does real-world evidence still need the physician? A live debate at the RWE crossroad
Anthropic's CEO says AI could cure most disease within a decade. The harder question is what happens to...
Medical device clinical trial platform one-pager
Castor replaces disconnected DM tools and CRO handoffs with one platform and one expert team. Fixed-fee, submission-ready.
The RWE Crossroad: the physician, the patient, or the machine?
Real-world evidence has more ways than ever to capture a patient's story: directly from patients, from medical records...
How device and diagnostic teams run compliant studies without enterprise EDC overhead
Medical device, diagnostic, and IVD teams face a hard trade-off. Enterprise EDC systems bring cost and build time...
Castor Essentials: the fastest route to compliant medical device trials
Early-stage medical device, diagnostic, and IVD teams face a hard trade-off: legacy EDCs are overkill for a pilot...
ICH E6(R3) Annex 2
ICH E6(R3) Annex 2, adopted 3 June 2026, establishes Good Clinical Practice standards for trials that use real-world...